Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies

Clinical trial NCT03818334 · RECRUITING

Trial details

NCT number: NCT03818334
Sponsor: Hospital Israelita Albert Einstein
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Bone Marrow Transplant Complications Graft Versus Host Disease Infection Viral Engraft Failure Immunologic Suppression

Start date: 2018-11-06
Primary completion: 2021-11-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.